FANDA Group represents a unique investment opportunity in the rapidly growing NBIC convergence sector. As the first converging sciences organization in the Middle East, we're positioned at the intersection of four transformative technologies.
The Strategic Importance of NBIC Convergence
NBIC convergence represents the most significant technological revolution of the 21st century. By integrating Nanotechnology, Biotechnology, Information Technology, and Cognitive Science, we're not just improving existing systems—we're creating entirely new paradigms for human enhancement, healthcare, and technological advancement.
Why Invest in FANDA?
First Mover Advantage
The first NBIC convergence group in the Middle East with established operations and proven track record
Diversified Portfolio
Strategic presence across four high-growth sectors: Nanotechnology, Biotechnology, Information Technology, and Cognitive Science
Established Subsidiaries
Two operational executive arms: Ariafan Varzan (AFV) and Farmed Tajhiz, each with revenue-generating products and services
Growing Market Demand
Addressing critical needs in healthcare, human enhancement, and advanced materials with increasing global demand
How to Invest
Our investment process is designed to be transparent and efficient. Follow these steps to become part of the NBIC revolution.
Initial Contact
Reach out to our investment team through the contact form or direct email
Due Diligence
Review our business documentation, white paper, and financial projections
Meeting & Discussion
Schedule a meeting with our executive team to discuss investment terms
Investment Agreement
Finalize legal agreements and investment structure
Business Documentation
Access our comprehensive business documentation to make informed investment decisions.
FANDA White Paper
Complete overview of our NBIC convergence approach, technology platforms, market analysis, and growth strategy
Executive Summary
Quick overview of investment opportunity and key financial metrics
Financial Projections
5-year revenue forecasts and growth projections across all business units
Technology Portfolio
Detailed documentation of our proprietary technologies and intellectual property
Download White Paper
Comprehensive overview of FANDA's technology, market strategy, and financial projections
Investment Focus Areas
Nanotechnology Solutions
Nanomaterials, nanocoatings, and molecular engineering applications
Global market projected to reach $125B by 2027
Biotechnology & Cell Therapy
Advanced cell culture, biopharmaceutical production, and regenerative medicine
Cell therapy market expected to exceed $20B by 2028
AI for Human Enhancement
Brain-computer interfaces, cognitive augmentation, and neural technologies
BCI market forecasted to reach $5B by 2030
Neuroscience Technologies
TMS therapy, neurofeedback systems, and cognitive training platforms
Neurotechnology market growing at 12% CAGR
Connect With Our Investment Team
investors@fandagroup.com
Phone
+98 21 88503633
Location
Tehran, Iran
